BioCryst Pharmaceuticals Shares Down 14.3% Since SmarTrend's Sell Call (BCRX) By: Comtex SmarTrend® News Briefs March 24, 2015 at 10:41 AM EDT Read More >> Related Stocks: Biocryst Pharma Inc